MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
attributable to common...
-$20,370K
Net income (loss)
-$17,368K
(-154.50%↓ Y/Y)
Deemed dividend on
warrants
-$3,002K
Income (loss) before
income taxes
-$17,130K
(-153.38%↓ Y/Y)
Provision for income taxes
$238K
(6.25%↑ Y/Y)
Interest income
$5,206K
(-27.05%↓ Y/Y)
Other income
(expense), net
$28K
(173.68%↑ Y/Y)
Income (loss) from
operations
-$22,364K
(-189.47%↓ Y/Y)
Revenue
$76,201K
(-44.82%↓ Y/Y)
Total operating
expenses
$98,565K
(-12.86%↓ Y/Y)
Research and development
$68,728K
(-17.57%↓ Y/Y)
General and
administrative
$29,837K
(0.37%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)